Corporate calendar for Lucid Diagnostics Inc. (LUCD): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | $0.18 | $607M |
| 2026-09-15 | $0.01 | $33M |
| 2026-09-15 | ||
| 2026-09-15 | $159M | |
| 2026-09-15 | $-0.01 | $34M |
| 2026-09-15 | $24M |
Price
| Price | $0.78 |
| Market Cap | $149M |
| Exchange | NASDAQ |
| Country | US |
Related companies: APYX · AVR · IRD · IXHL · OWLT · RCEL · RPID
Explore sector: Healthcare · Medical - Devices
More sections of LUCD: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks